You are here

  • Home
  • Online First
  • COVID-19-related nationwide lockdown did not reduce the reported diagnoses of Chlamydia trachomatis and Neisseria gonorrhoeae in Finland

Article Text

Article menu

Download PDFPDF

Research Letter
COVID-19-related nationwide lockdown did not reduce the reported diagnoses of Chlamydia trachomatis and Neisseria gonorrhoeae in Finland
Free
  1. Ilari Kuitunen1,2,
  2. Ville Ponkilainen3
  1. 1Mikkeli Central Hospital, Mikkeli, Finland
  2. 2School of Medicine, University of Eastern Finland, Kuopio, Finland
  3. 3Central Finland Hospital District, Jyvaskyla, Finland
  1. Correspondence to Dr Ilari Kuitunen, Mikkeli Central Hospital, 50100 Mikkeli, Finland; ilari.kuitunen{at}uef.fi
View Full Text

http://dx.doi.org/10.1136/sextrans-2020-054881

Statistics from Altmetric.com

    There has been interest in exploring the impact of COVID-19-related lockdowns on sexual and reproductive health, with studies reporting a decrease in the self-reported number of new sexual partners and frequency of intercourse.1 2 The importance of information on the incidence of STIs has also been highlighted.3 4

    In Finland, national lockdown in response to the COVID-19 pandemic began on 16 March 2020. The first wave did not cause a healthcare surge and the rate of new cases started to decrease in May. Restrictions were loosened in early June. Our aim was to explore cross-sectionally the influence of social restrictions on the number of laboratory-confirmed Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) diagnoses among people aged ≥15 during the period of January–August 2020. Diagnoses reported in 2015–2019 were used as …

    View Full Text

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Copyright information:

    © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage